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Editorials and Perspectives
745 A role for the renin-angiotensin system 
in hematopoiesis
Tea Soon Park and Elias T. Zambidis
In this perspective article, Drs. Park and Zambidis give a
comprehensive overview of the role of the renin-angiotensin
system. They highlight that its broad function goes beyond
the well-characterized activities in maintaining cardiovas-
cular homeostasis. See related article on page 857. 
748 Bridging the gap between the north and south
of the world: the case of treatment response 
in childhood acute lymphoblastic leukemia
Martin Stanulla and André Schrauder
Minimal residual disease (MRD) analyses provide strong
prognostic information and can be used to identify a major-
ity of patients with childhood acute lymphoblastic leukemia
at a high risk of relapse. In this perspective article, Drs.
Stanulla and Schrauder comprehensively summarize the
current knowledge in the field and how simplified MRD
analyses can be successfully implemented also in countries
with limited economic resources. See related articles on
page 781 and 870.
752 Chronic lymphocytic leukemia 
microenvironment: shifting the balance
from apoptosis to proliferation
Silvia Deaglio and Fabio Malavasi
Most information on chronic lymphocytic leukemia has
been derived from circulating cells, but, proliferation occurs
in tissue sites. Drs. Deaglio and Malavasi examine critical
receptor/ligand interactions likely to influence growth or
apoptosis in the tissue microenvironment. See related paper
on page 790.
756 The regulation of proplatelet production
Amy E. Geddis
The process by which megakaryocytes break down into
platelets is slowly becoming clearer. It is now clear that
these processes also determine the morphology of the
platelets that are formed. Dr Geddis here summarizes
recent work using in vitro and in vivo models, which
demonstrate how factors within the megakaryocyte and
their interactions with the marrow environment give rise to
normal and abnormal platelets. See related article on page
800.
759 Definition, diagnosis and treatment
of immune thrombocytopenic purpura
James N. George
Novel drugs have recently been approved for the treatment
of immune thrombocytopenic purpura. In this perspective
article, Dr. George examines definition, diagnosis and
treatment of this condition. See related article on page 850.
762 α1-antitrypsin and the maintenance 
of hemostatic balance
Joseph Emmerich
Although antitrypsin usually plays only minor role in
hemostasis, a single point mutation can convert it into a
potent inhibitor of thrombin and produce an associated
bleeding tendency. In this perspective article, Dr. Emmerich
compares the phenotype and laboratory findings in the
three available reports of this rare phenomenon.
See related article on page 881.
764 Paying for open access
Haematologica is owned by a non-profit organization, the
Ferrata Storti Foundation, and serves the scientific commu-
nity with strict adherence to the principles of open access
publishing. A number of recent initiatives aimed at improv-
ing the journal further have had a significant impact on
production costs. To continue to provide open access, the
journal now needs to share these high costs of publication




765 Cross-talk between the mitogen activated 
protein kinase and bone  morphogenetic 
protein/hemojuvelin pathways is required for
the induction of hepcidin by holotransferrin 
in primary mouse hepatocytes
Guillemette Ramey, Jean-Christophe Deschemin, 
and Sophie Vaulont
The circulating hormone hepcidin plays a central role in
iron homeostasis. The findings of this study show that
transcriptional activation of hepcidin by holotransferrin
occurs in primary mouse hepatocytes through both
BMP/HJV and TFR2/ERK pathways. 
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773 Activated macrophages induce hepcidin 
expression in HuH7 hepatoma cells
Pavle Matak, Timothy B. Chaston, Bomee Chung,
Surjit Kaila Srai, Andrew T. McKie,
and Paul A. Sharp
Macrophage-released cytokines are relevant in modulating
hepcidin expression. The findings of this study suggest that
the interleukin-1β and bone morphogenetic protein signal-
ing pathways are central to the regulation of hepcidin
expression by macrophages.
Acute Lymphoblastic Leukemia
781 A simplified minimal residual disease 
polymerase chain reaction method at early
treatment points can stratify children with
acute lymphoblastic leukemia into good and
poor outcome groups
Carlos A. Scrideli, Juliana G. Assumpção, 
Mônica A. Ganazza, Marcela Araújo, 
Silvia R. Toledo, Maria Lúcia M. Lee, Elisabete
Delbuono, Antonio S. Petrilli, Rosane P. Queiróz,
Andrea Biondi, Marcos B. Viana, José A. Yunes, 
Silvia R. Brandalise, and Luiz G. Tone
This paper describes a simplified PCR strategy for minimal
residual disease (MRD) monitoring in children with acute
lymphoblastic leukemia. Since this method is cheaper and
simpler than standard methods, it may be particularly suit-
able for countries with limited economic resources.
See related perspective article on page 748.
Chronic Lymphocytic Leukemia
790 Gene expression profiling reveals differences
in microenvironment interaction between
patients with chronic lymphocytic leukemia
expressing high versus low ZAP70 mRNA
Basile Stamatopoulos, Benjamin Haibe-Kains, 
Carole Equeter, Nathalie Meuleman, Anne Sorée,
Cécile de Bruyn, Delphine Hanosset, 
Dominique Bron, Philippe Martiat,
and Laurence Lagneaux
ZAP70 is a strong indicator of poor prognosis in chronic
lymphocytic leukemia. In this study, using gene expression
profiles associated with ZAP70 expression, the importance
of microenvironmental interaction for tumor behavior is
revealed. See related perspective article on page 752. 
Platelet Disorders
800 Intrinsic impaired proplatelet formation and
microtubule coil assembly of megakaryocytes
in a mouse model of Bernard-Soulier syndrome
Catherine Strassel, Anita Eckly, Catherine Léon, Claire
Petitjean, Monique Freund, Jean-Pierre Cazenave,
Christian Gachet, and François Lanza
Bernard-Soulier syndrome is caused by a deficiency of the
platelet surface glycoprotein Ib-IX-V complex resulting in a
severe platelet function defect. However this is compounded
by a reduction in platelet numbers and the platelets in the
circulation are abnormally large. As for many other platelet
disorders, recent evidence and findings of this study suggest
that the defective morphology has its origins in megakary-
ocyte function. See related perspective article on page 756. 
Thrombosis
811 Low TAFI activity levels are associated with
an increased risk of a first myocardial
infarction in men
Mirjam E. Meltzer, Carine J.M. Doggen, 
Philip G. de Groot, Joost C.M. Meijers, 
Frits R. Rosendaal, and Ton Lisman
Case control studies can be useful ways of investigating
mechanisms of disease but demonstrate associations rather
than proving causes. Thus it should not be surprising that
the results are sometimes not intuitively obvious or run
counter to what is expected. In this report from a large
case-control study this is exactly what has occurred.
Corresponding genetic analyses are unable to resolve the
problem, but the complexity of the coagulation system and
its relationship with inflammation is able to provide alter-
native explanations. 
Hemostasis
819 Tissue factor-expressing monocytes inhibit 
fibrinolysis through a TAFI-mediated 
mechanism, and make clots resistant 
to heparins
Fabrizio Semeraro, Concetta T. Ammollo, 
Nicola Semeraro, and Mario Colucci
It is often noted that the activation of the fibrinolytic system
begins as the clot is formed, but it is also true that antifibri-
nolytic mechanisms are activated at the same time and
both depend on the generation of thrombin. In this paper,
the authors show that the increased thrombin generation
driven by monocyte-associated tissue factor activates TAFI
and thus make the clot more resistant to fibrinolysis. 
Stem Cell Transplantation
827 Impact of hematopoietic chimerism at day +14
on engraftment after unrelated donor umbilical
cord blood transplantation for hematologic
malignancies
Federico Moscardó, Jaime Sanz, Leonor Senent, 
Susana Cantero, Javier de la Rubia, Pau Montesinos,
Dolores Planelles, Ignacio Lorenzo, Jose Cervera,
Javier Palau, Miguel A. Sanz, and Guillermo F. Sanz
Primary graft failure remains a substantial setback of
umbilical cord blood transplantation (CBT). The results of
this study emphasize that the extent of donor chimerism
very early post-transplant is predictive of hematopoietic
engraftment following single-unit CBT in adult patients
suffering from malignant hematologic disease. 
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Infectious Disorders
833 Multicluster nosocomial outbreak 
of parainfluenza virus type 3 infection 
in a pediatric Oncohematology Unit: 
a phylogenetic study
Antonio Piralla, Elena Percivalle, 
Alessandra Di Cesare-Merlone, Franco Locatelli, 
and Giuseppe Gerna
Human parainfluenza virus type 3 (hPIV-3) has been
reported to cause nosocomial outbreaks of respiratory
infection, in particular among hematopoietic stem cell
transplant. The results of the present study indicate that
a nosocomial outbreak of hPIV-3 infection occurred among
patients followed in an Oncohematology Unit over a period
of about 15 weeks during the fall season. 
Review Article
Iron Metabolism
840 Matriptase-2 (TMPRSS6): a proteolytic 
regulator of iron homeostasis
Andrew J. Ramsay, John D. Hooper, 
Alicia R. Folgueras, Gloria Velasco, 
and Carlos López-Otín
The family of membrane anchored serine proteases is
increasingly being acknowledged as having critical physio-
logical functions, exemplified recently by the discovery of
the iron regulatory role of matriptase-2. This protease,
encoded by TMRPSS6, has a specific role in hepcidin inhi-
bition and iron absorption. In this review article, the
authors discuss our current knowledge on this new and
exciting issue. 
Decision Making and Problem Solving
Platelet Disorders
850 Platelet count response to H. pylori treatment
in patients with immune thrombocytopenic
purpura with and without H. pylori infection:
a systematic review 
Donald M. Arnold, Ashley Bernotas, Ishac Nazi,
Roberto Stasi, Masataka Kuwana, Yang Liu, 
John G. Kelton, and Mark Crowther
Eradication of H. pylori improves thrombocytopenia in
some patients with immune thrombocytopenic purpura by
mechanisms that remain obscure. To determine the inde-
pendent effect of H. pylori eradication therapy on platelet
count response, the authors performed a systematic review
of all studies reporting treatment responses compared to H.
pylori-negative controls. The findings strengthen the
causal association between H. pylori infection and
immune thrombocytopenia in some patients.
See related perspective article on page 759.
Brief Reports
Hematopoiesis
857 Angiotensin-(1-7) stimulates hematopoietic
progenitor cells in vitro and in vivo
Silvia Heringer-Walther, Klaus Eckert, 
Sarah-Mai Schumacher, Lutz Uharek, 
Annika Wulf-Goldenberg, Florian Gembardt, 
Iduna Fichtner, Heinz-Peter Schultheiss, 
Kathy Rodgers, and Thomas Walther
This study demonstrates that the angiotensin II metabolite
Ang-(1-7) stimulates the proliferation of hematopoietic pro-
genitor cells and promotes their engraftment in a xenograft
model, suggesting that the renin-angiotensin system is a
regulator of blood cell formation. See related perspective
article on page 745. 
Chronic Myeloid Leukemia
861 The level of BCR-ABL1 kinase activity before
treatment does not identify chronic myeloid
leukemia patients who fail to achieve a 
complete cytogenetic response on imatinib 
Jamshid Sorouri Khorashad, Simon Wagner, 
Liat Greener, David Marin, Alistair Reid, 
Dragana Milojkovic, Hetal Patel, Shaun Willimott, 
Katy Rezvani, Gareth Gerrard, Sandra Loaiza, 
John Davis, John Goldman, Junia Melo, Jane Apperley,
and Letizia Foroni 
This study investigated the in vitro inhibition of Crkl
phosphorylation by imatinib in CD34+ cells from patients
with chronic myeloid leukemia, and showed that it does not
correlate with the cytogenetic response, possibly indicating
that BCR-ABL1-independent resistance mechanisms exist. 
Myeloproliferative Neoplasms
865 Significant increase in the apparent incidence
of essential thrombocythemia related
to new WHO diagnostic criteria:
a population-based study
François Girodon, Gilles Bonicelli, Céline Schaeffer,
Morgane Mounier, Serge Carillo, Ingrid Lafon, 
Paule Marie Carli, Inès Janoray, Emmanuelle Ferrant,
and Marc Maynadié
The findings of this study confirm the relevance of the new
WHO diagnostic criteria in allowing earlier diagnosis of
essential thrombocythemia. 
Acute Lymphoblastic Leukemia
870 Establishment and validation of a standard 
protocol for the detection of minimal 
residual disease in B lineage childhood acute
lymphoblastic leukemia by flow cytometry 
in a multi-center setting
Julie Irving, Jenny Jesson, Paul Virgo, Marian Case,
Lynne Minto, Lisa Eyre, Nigel Noel, Ulrika Johansson,
Table of Contents
June 2009
Haematologica/The Hematology Journal 2009; vol. 94; no. 6- June 2009
http://www.haematologica-thj.org/
Marion Macey, Linda Knotts, Margaret Helliwell, 
Paul Davies, Liam Whitby, David Barnett, 
Jeremy Hancock, Nick Goulden, and Sarah Lawson 
on behalf of the UKALL Flow MRD group 
and UK MRD steering group
Flow cytometry to detect minimal residual disease is a sen-
sitive and specific means to detect impending relapse in B
lineage acute lymphoblastic leukemia (ALL). However as
with all relatively sophisticated procedures assurance is
needed that the methodology is widely applicable, and
reproducible in different laboratories. In this paper, the UK
ALL Flow MRD Group and the UK MRD steering group
describe a four color flow protocol that was applicable to
most patients and showed similarly high levels of concor-
dance both between different laboratories and with MRD
as detected molecularly. See related perspective article on
page 748. 
Malignant Lymphomas
875 CD4 counts and the risk of systemic 
non-Hodgkin’s lymphoma in individuals 
with HIV in the UK
Mark Bower, Martin Fisher, Teresa Hill, Iain Reeves,
John Walsh, Chloe Orkin, Andrew N. Phillips,
Loveleen Bansi, Richard Gilson, Philippa Easterbrook,
Margaret Johnson, Brian Gazzard, Clifford Leen,
Deenan Pillay, Achim Schwenk, Jane Anderson,
Kholoud Porter, Mark Gompels, and Caroline A. Sabin
for the UK CHIC Steering Committee
This very large HIV-positive cohort study examines a
number of variables that predispose to the development of
lymphoma in the HAART era. Despite a declining inci-
dence of lymphoma, the authors define a close relationship
between latest CD4 count and lymphoma risk, and thus
advocate early initiation of HAART and more frequent
HIV monitoring. 
Disorders of Hemostasis
881 α1-antitrypsin Pittsburgh in a family 
with bleeding tendency
Baolai Hua, Liankai Fan, Yan Liang, Yongqiang Zhao,
and Edward G.D. Tuddenham
A rare but naturally occurring mutation turns alpha1 antit-
rypsin into a potent antithrombin resulting in a bleeding
tendency. This extremely rare phenomenon has been
described before, but this additional family provides an
interesting insight into the balance of coagulation. 
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885 Regulation of serum hepcidin levels
in sickle cell disease
Joyce J.C. Kroot, Coby M.M. Laarakkers, 
Erwin H.J.M. Kemna, Bart J. Biemond, 
and Dorine W. Swinkels
Chronic Lymphocytic Leukemia
887 Predictive value of β2-microglobulin 
levels in Binet A stage chronic lymphocytic
leukemia
Massimo Gentile, Giovanna Cutrona, Antonino Neri,
Stefano Molica, Manlio Ferrarini, 
and Fortunato Morabito
Blood Doping
888 Detection of continuous erythropoietin 
receptor activator in blood and urine 
in anti-doping controls
Françoise Lasne, Laurent Martin, Jean Antoine Martin,
and Jacques de Ceaurriz
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